When you live with multiple myeloma, fatigue can feel like a constant companion, following you wherever you go and affecting whatever you try to do. It can be so pervasive, you may have… Read More

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. The… Read More

United States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully increase the survival rate of patients withou… Read More

Targeted protein degradation (TPD) is an emerging protein degradation technology in recent decades that utilizes the cell’s own protein clearance mechanisms, such as lysosomal deg… Read More

This small cap pharma stock slumped 4% in the first half on Friday after the company announced its involvement in an antitrust lawsuit in the US by Louisiana Health Service & Indemnity C… Read More

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More

Shares of Bristol Myers Squibb (BMY) experienced a decline in premarket trading following the company’s report of lower-than-expected second-quarter sales and a revision of its financi… Read More

Immunotherapy is one of the most recent approaches for cancer therapy. It is a treatment that uses body’s own immune system to help fight canc… Read More

The growing prevalence of the Kaposi Sarcoma and the rising number of patients undergoing organ transplantation procedures as patients undergoing organ transplantations are more susceptible… Read More

Amid a choppy session on Friday, benchmark indices recovered most of their losses, tracking mixed moves across global markets. Worries remained about the impact of aggressive hikes in benchm… Read More

Kenneth Research has evaluated the current market opportunities in Oncology Cancer Blockbuster Drugs Market in the healthcare industry for the forecast period 2022-2031, which… Read More

Boyd Huppert multiple myeloma or simply multiple myeloma is one of the rare kinds of cancer that develops in the plasma cells, a subtype of your WBCs. Plasma cells are present mainly in the… Read More

We all know that cancer treatments are performed to kill or remove cancer cells and tumors. The most common cancer treatments are chemotherapy, surgery, and radiation. They all are quite ef… Read More

 Orphan Drugs Market Research Report: Information by Drug Type (Biologics & Non-Biologics), Sale (Generics & Prescribed), Drug (Revlimid, Rituxan, Opdivo, & Others), Therapy… Read More

The global orphan drugs market is expected to exhibit a strong 11.50% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MR… Read More

The global orphan drugs market is expected to exhibit a strong 11.50% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MR… Read More

New Delhi: Drug major Natco Pharma on Friday said its marketing partner Breckenridge Pharmaceutical has received final approval from the US health regulator for Pomalidomide Capsules, treatm… Read More

Not even close, doing pretty well actually, though I should post more often. I was diagnosed with myeloma in July, 2003, and according to my math that's well over 16 years ago. My family and… Read More

Dresden, Deutschland (ots/PRNewswire) – GEMoaB GmbH, ein biopharmazeutisches Unternehmen, das sich auf die Entdeckung, Entwicklung, Herstellung und Vermarktung von Immuntherapien de… Read More

National Pension Service raised its stake in shares of Celgene Co. (NASDAQ:CELG) by 0.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange C… Read More

Celgene Corporation (NDAQ:CELG) Rating Downgrade Bernstein cut the shares of Celgene Corporation (NDAQ:CELG) from a Outperform rating to Mkt Perform rating in a note published on 27 Decemb… Read More

June 22, 2016Bright Sun:After the 10th Darzalex infusion, with daily 2 mg Pomalyst and weekly dexamethasone (DEX), IgG is down once again, from 644 to 515 mg/dL, another drop of 20%.  M… Read More